Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

Overview of attention for article published in BMC Medicine, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 4 Mendeley

Summary News X Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases | BMC Medicine

User montaukwhaler, in the non small cell lung cancer subreddit, 04 Jun 2022

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.